Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6476)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mahipal A, Frakes J, Hoffe S, Kim R. Management of borderline resectable pancreatic cancer. World J Gastrointest Oncol 2015; 7(10): 241-249 [PMID: 26483878 DOI: 10.4251/wjgo.v7.i10.241] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i10/241.htm |
| Number | Citing Articles |
| 1 |
Anuhya Kommalapati, Sri Tella, Gaurav Goyal, Wen Ma, Amit Mahipal. Contemporary Management of Localized Resectable Pancreatic Cancer. Cancers 2018; 10(1): 24 doi: 10.3390/cancers10010024
|
| 2 |
Christoph W. Michalski, Max Heckler, Mert Erkan, Markus W. Büchler. The Pancreas. 2018; : 823 doi: 10.1002/9781119188421.ch109
|
| 3 |
Zhi Cheng, Lauren M. Rosati, Linda Chen, Omar Y. Mian, Yilin Cao, Marta Villafania, Minoru Nakatsugawa, Joseph A. Moore, Scott P. Robertson, Juan Jackson, Amy Hacker-Prietz, Jin He, Christopher L. Wolfgang, Matthew J. Weiss, Joseph M. Herman, Amol K. Narang, Todd R. McNutt. Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy. Advances in Radiation Oncology 2018; 3(4): 601 doi: 10.1016/j.adro.2018.07.002
|
| 4 |
I. Montejo Gañán, L.F. Ángel Ríos, L. Sarría Octavio de Toledo, M.E. Martínez Mombila, L.H. Ros Mendoza. Staging pancreatic carcinoma by computed tomography. Radiología (English Edition) 2018; 60(1): 10 doi: 10.1016/j.rxeng.2017.08.003
|
| 5 |
Danielle K. DePeralta, Jessica Frakes, Amit Mahipal, Nadia Saeed, Kaldhoun Almhanna, Richard Kim, Daniel A. Anaya. Geriatric Oncology. 2020; : 731 doi: 10.1007/978-3-319-57415-8_28
|
| 6 |
Josef Gillson, Yomna S. Abd El-Aziz, Lionel Y. W. Leck, Patric J. Jansson, Nick Pavlakis, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target. Cancers 2022; 14(14): 3528 doi: 10.3390/cancers14143528
|
| 7 |
Maciej Słodkowski, Marek Wroński, Dominika Karkocha, Leszek Kraj, Kaja Śmigielska, Aneta Jachnis. Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(9): 2584 doi: 10.3390/cancers15092584
|
| 8 |
Robert Memba, Donal B. O’Connor, Kevin C. Conlon. Minimally Invasive Surgery of the Pancreas. Updates in Surgery 2018; : 75 doi: 10.1007/978-88-470-3958-2_8
|
| 9 |
Andreas Minh Luu, Philipp Hoehn, Sina Rabea Vogel, Anke Reinacher-Schick, Johanna Munding, Waldemar Uhl, Chris Braumann. Pathologic Complete Response of Pancreatic Cancer following Neoadjuvant FOLFIRINOX Treatment in Hepatic Metastasized Pancreatic Cancer. Visceral Medicine 2019; 35(6): 387 doi: 10.1159/000497827
|
| 10 |
Mark Yarchoan, Melinda C. Myzak, Burles A. Johnson, Ana De Jesus-Acosta, Dung T. Le, Elizabeth M. Jaffee, Nilofer S. Azad, Ross C. Donehower, Lei Zheng, Paul E. Oberstein, Robert L. Fine, Daniel A. Laheru, Michael Goggins. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer. Oncotarget 2017; 8(27): 44073 doi: 10.18632/oncotarget.17237
|
| 11 |
Amit Mahipal, Richard Kim. Current and Emerging Therapies in Pancreatic Cancer. 2018; : 109 doi: 10.1007/978-3-319-58256-6_5
|
| 12 |
Chien-Ting Kao, Muhammad Aziz, Anup Kasi. Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX. BMJ Case Reports 2018; : bcr-2018-225621 doi: 10.1136/bcr-2018-225621
|
| 13 |
I. Montejo Gañán, L.F. Ángel Ríos, L. Sarría Octavio de Toledo, M.E. Martínez Mombila, L.H. Ros Mendoza. Estadificación mediante tomografía computarizada del carcinoma de páncreas. Radiología 2018; 60(1): 10 doi: 10.1016/j.rx.2017.08.004
|
| 14 |
Daniel Ansari, Bobby Tingstedt, Bodil Andersson, Fredrik Holmquist, Christian Sturesson, Caroline Williamsson, Agata Sasor, David Borg, Monika Bauden, Roland Andersson. Pancreatic cancer: yesterday, today and tomorrow. Future Oncology 2016; 12(16): 1929 doi: 10.2217/fon-2016-0010
|
| 15 |
Peter Götzinger. Pankreaskarzinom: Chirurgische Konzepte zur kompletten Tumorentfernung. Journal für Gastroenterologische und Hepatologische Erkrankungen 2018; 16(3): 80 doi: 10.1007/s41971-018-0032-z
|
| 16 |
Chandrayee Ghosh, Santanu Paul, Prasad Dandawate, Sumedha S. Gunewardena, Dharmalingam Subramaniam, Cameron West, Shrikant Anant, Animesh Dhar. Super-enhancers: novel target for pancreatic ductal adenocarcinoma. Oncotarget 2019; 10(16): 1554 doi: 10.18632/oncotarget.26704
|
| 17 |
Walid L. Shaib, Natalyn Hawk, Richard J. Cassidy, Zhengjia Chen, Chao Zhang, Edith Brutcher, David Kooby, Shishir K. Maithel, Juan M. Sarmiento, Jerome Landry, Bassel F. El-Rayes. A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458). International Journal of Radiation Oncology*Biology*Physics 2016; 96(2): 296 doi: 10.1016/j.ijrobp.2016.05.010
|
| 18 |
Danielle K. DePeralta, Jessica Frakes, Amit Mahipal, Nadia Saeed, Kaldhoun Almhanna, Richard Kim, Daniel A. Anaya. Geriatric Oncology. 2019; : 1 doi: 10.1007/978-3-319-44870-1_28-1
|
| 19 |
Burles A. Johnson, Mark Yarchoan, Valerie Lee, Daniel A. Laheru, Elizabeth M. Jaffee. Strategies for Increasing Pancreatic Tumor Immunogenicity. Clinical Cancer Research 2017; 23(7): 1656 doi: 10.1158/1078-0432.CCR-16-2318
|
| 20 |
Shengyuan Zhao, Rodan Devega, Aaliyah Francois, Dawit Kidane. Human ALKBH6 Is Required for Maintenance of Genomic Stability and Promoting Cell Survival During Exposure of Alkylating Agents in Pancreatic Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.635808
|
| 21 |
Helen S. Earley, Vikram Tewatia, Kevin C. Conlon. Textbook of Pancreatic Cancer. 2021; : 817 doi: 10.1007/978-3-030-53786-9_52
|
| 22 |
Emil Sahlström, Paulina Bereza-Carlson, Johan Nilsson, Bobby Tingstedt, Bodil Andersson. Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease: A national cohort study. Hepatobiliary & Pancreatic Diseases International 2022; 21(3): 279 doi: 10.1016/j.hbpd.2022.02.003
|
| 23 |
Ulrike Heger, Huihui Sun, Ulf Hinz, Ulla Klaiber, Masayuki Tanaka, Bing Liu, Milena Sachsenmaier, Christoph Springfeld, Christoph W. Michalski, Markus W. Büchler, Thilo Hackert. Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival. HPB 2020; 22(2): 224 doi: 10.1016/j.hpb.2019.06.012
|
| 24 |
Kira C. Steinkraus, Max Heckler, Christoph W. Michalski, Felix J. Hüttner. The Pancreas. 2023; : 1108 doi: 10.1002/9781119876007.ch142
|